LLY’s 5,464,826 “use” patent will probably not hold but the compound patent expires on November 15, 2010, so I assume Teva thinks the compound patent is strong and the risk is not worth if they can get a "clean" launch on Nov. 2010. Anyway Teva has to give 3 months notice to LLY before.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.